Open Actively Recruiting

Prevention of Colorectal Cancer Through Multiomics Blood Testing

About

Brief Summary

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Study Type
Observational
Phase
N/A (Cancer Prevention)

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
45 Years
Maximum Age
85 Years

Key Inclusion Criteria

  • 45-85 years of age
  • Willing to undergo a standard-of-care screening colonoscopy
  • Able and willing to provide a blood sample
  • Able and willing to sign informed consent

Key Exclusion Criteria

  • Known hereditary gastrointestinal cancer syndrome (for example, hereditary non-polyposis CRC syndrome (HNPCC) or Lynch syndrome, or familial adenomatous polyposis (FAP)
  • Personal history 2.1 CRC or colorectal adenoma 2.2 Inflammatory bowel disease (IBD), including chronic ulcerative colitis (CUC) and crohn's disease (CD) 2.3 Colonoscopy in the 9 years preceding enrollment 2.4 Stool DNA testing in the 2 years preceding enrollment 2.5 Symptoms of lower gastrointestinal tract disease warranting colonoscopic evaluation
  • A medical condition which, in the opinion of the Investigator, should preclude enrollment in the study
  • Participated or currently participating in a clinical research study in which an experimental medication has been administered during the 60 days up to and including the date of providing informed consent or may be administered through the time of the colonoscopy

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
20-002176
Category
Gastroenterology
Oncology
Contact
Melissa Arevalo
Location
  • UCLA Santa Monica
  • UCLA Westlake Village
  • UCLA Westwood
For Providers
NCT No.
NCT04369053
For detailed technical eligibility, visit ClinicalTrials.gov.